Literature DB >> 17156595

Role of thiamine in managing ifosfamide-induced encephalopathy.

Mehdi Hamadani1, Farrukh Awan.   

Abstract

Encephalopathy is a well known side effect of ifosfamide, developing in approximately 10-30% of patients exposed to the drug. It is generally reversible after discontinuing the therapy; however cases of fatal neurotoxicity have been reported. Methylene blue is commonly used in the treatment and prophylaxis of ifosfamide induced encephalopathy; however its efficacy is moderate at best. We report here the utility of thiamine in both treating and preventing ifosfamide induced neurotoxicity in three patients. With the use of intravenous thiamine encephalopathy resolved in all of our patients within a mean time of 17 hours (range 10-30 hours). In three cycles where thiamine was used as prophylaxis no evidence of ifosfamide induced encephalopathy was seen. Thiamine appears to be a safe and effective treatment for reversing encephalopathy resulting form ifosfamide infusion, without any significant side effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156595     DOI: 10.1177/1078155206073553

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  4 in total

1.  Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.

Authors:  Antonella Brunello; Umberto Basso; Elena Rossi; Micaela Stefani; Cristina Ghiotto; Dario Marino; Gino Crivellari; Silvio Monfardini
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

2.  Severe ifosfamide-induced neurotoxicity: a case report.

Authors:  Sara Ramos Linares; Joaquín Breña Atienza; Matilde Cháfer Rudilla; Pablo Ríos Rull; Ana Cabello Rodríguez; Javier Merino Alonso
Journal:  Pharm World Sci       Date:  2009-12-23

Review 3.  Risk Factors for Ifosfamide-Related Encephalopathy in Adult Cancer Patients: An Integrative Review.

Authors:  Amanda Lee Brink; Christi Bowe; Joyce E Dains
Journal:  J Adv Pract Oncol       Date:  2020-05-01

4.  Linking vitamin B1 with cancer cell metabolism.

Authors:  Jason A Zastre; Rebecca L Sweet; Bradley S Hanberry; Star Ye
Journal:  Cancer Metab       Date:  2013-07-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.